SCHEMBL8844174

SCHEMBL8844174

O=C(O)C(C(C(=O)O)P(=O)(O)O)n1ccnc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FDPS P14324 3/20 0.40
CYP19A1 P11511 1/20 0.35
BTN3A1 O00481 1/20 0.35
CA12 O43570 1/20 0.35
GGPS1 O95749 1/20 0.35
CA2 P00918 1/20 0.35
LMNA P02545 1/20 0.35
MMP2 P08253 1/20 0.35
MMP9 P14780 1/20 0.35
MMP8 P22894 1/20 0.35
MMP14 P50281 1/20 0.35
CA9 Q16790 1/20 0.35
CA14 Q9ULX7 1/20 0.35
KDM4E B2RXH2 1/20 0.34
CYP26A1 O43174 8/20 0.33
ALDH1A1 P00352 1/20 0.33
CYP24A1 Q07973 2/20 0.33
TBXAS1 P24557 2/20 0.33
FOLH1 Q04609 1/20 0.32
CYP17A1 P05093 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9738425 0.75 KDM4E (0.43) CYP19A1KDM4ECYP26A1ALDH1A1CYP24A1
SCHEMBL12002759 0.74 KDM4E (0.42) CYP19A1KDM4ECYP26A1ALDH1A1TBXAS1
SCHEMBL9114540 0.71 FDPS (0.61) FDPSBTN3A1CA12GGPS1CA2
SCHEMBL240573 0.70 FDPS (0.43) FDPSCYP19A1BTN3A1CA12GGPS1
SCHEMBL29035500 0.70 CYP19A1 (0.44) CYP19A1KDM4ECYP26A1ALDH1A1TBXAS1
SCHEMBL13225801 0.70 KDM4E (0.43) KDM4ECYP26A1ALDH1A1CYP24A1TBXAS1
SCHEMBL8843686 0.70 FDPS (0.59) FDPSBTN3A1CA12GGPS1CA2
Water SCHEMBL2111846 0.69 FDPS (0.42) FDPSCYP19A1BTN3A1CA12GGPS1
Hydrochloric Acid SCHEMBL28610443 0.69 CYP19A1 (0.42) CYP19A1KDM4ECYP26A1ALDH1A1TBXAS1
SCHEMBL7245729 0.68 FDPS (0.44) FDPSCYP19A1BTN3A1CA12GGPS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5627170-A Phosphonic acid compound containing heterocyclic substituents, pharmaceutical composition contains same and a method of treating calcium metabolism disturbance BOEHRINGER MANNHEIM GMBH (DE) 1997-05-06 US disclosed
US-5538957-A OSTEOPOROSIS BOEHRINGER MANNHEIM GMBH (DE) 1996-07-23 US disclosed